Arcus Biosciences (RCUS) News Today $10.51 +0.03 (+0.28%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$10.60 +0.09 (+0.87%) As of 07:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RCUS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Arcus Biosciences, Inc. $RCUS Stock Holdings Lifted by Algert Global LLCAugust 24 at 4:29 AM | marketbeat.comArcus Biosciences, Inc. $RCUS Shares Purchased by Public Sector Pension Investment BoardAugust 24 at 3:42 AM | marketbeat.comArcus Biosciences to Participate in Three Upcoming Investor ConferencesAugust 22 at 10:37 PM | theglobeandmail.comGilead Sciences Inc. Raises Position in Arcus Biosciences, Inc. (NYSE:RCUS)August 19, 2025 | marketbeat.comJim Cramer on Arcus Biosciences: “Let This Be Your Speculation”August 16, 2025 | finance.yahoo.comAnalysts Set Arcus Biosciences, Inc. (NYSE:RCUS) Price Target at $21.14August 15, 2025 | americanbankingnews.comCramer's Lightning Round: Uranium Energy is a buyAugust 14, 2025 | msn.comArcus Biosciences, Inc. (NYSE:RCUS) Receives Average Recommendation of "Moderate Buy" from BrokeragesAugust 12, 2025 | marketbeat.comCantor Fitzgerald Issues Positive Forecast for RCUS EarningsAugust 11, 2025 | marketbeat.comQ3 EPS Forecast for Arcus Biosciences Reduced by AnalystAugust 11, 2025 | marketbeat.comLeerink Partnrs Has Negative Estimate for RCUS Q3 EarningsAugust 11, 2025 | marketbeat.comWedbush Forecasts Lower Earnings for Arcus BiosciencesAugust 11, 2025 | marketbeat.comArcus Biosciences: A Risky Buy Ahead Of Pivotal, Catalyst-Rich 12 MonthsAugust 10, 2025 | seekingalpha.comArcus Biosciences (NYSE:RCUS) Stock Rating Upgraded by Wall Street ZenAugust 10, 2025 | marketbeat.comWedbush Decreases Earnings Estimates for Arcus BiosciencesAugust 9, 2025 | marketbeat.comArcus Biosciences (NYSE:RCUS) Price Target Lowered to $25.00 at Wells Fargo & CompanyAugust 8, 2025 | marketbeat.comArcus (RCUS) Q2 Revenue Jumps 310%August 6, 2025 | fool.comArcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline UpdateAugust 6, 2025 | gurufocus.comArcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline UpdateAugust 6, 2025 | businesswire.comArcus Biosciences’ Pancreatic Cancer Drug Quemliclustat Receives Orphan Drug Designation from FDAJuly 31, 2025 | msn.comArcus Biosciences (RCUS) Projected to Post Quarterly Earnings on WednesdayJuly 31, 2025 | marketbeat.comY Intercept Hong Kong Ltd Makes New Investment in Arcus Biosciences, Inc. (NYSE:RCUS)July 31, 2025 | marketbeat.comArcus Biosciences, Inc. (NYSE:RCUS) Shares Acquired by GSA Capital Partners LLPJuly 30, 2025 | marketbeat.comGilead and Arcus Biosciences’ Promising Lung Cancer Study: Market ImplicationsJuly 24, 2025 | msn.comArcus Biosciences Announces New Employment Inducement GrantsJuly 24, 2025 | businesswire.comPrecision BioSciences shares climb after FDA grants orphan drug statusJuly 23, 2025 | msn.comPrecision BioSciences stock rises after FDA grants orphan drug statusJuly 23, 2025 | investing.comPrincipal Financial Group Inc. Boosts Holdings in Arcus Biosciences, Inc. (NYSE:RCUS)July 19, 2025 | marketbeat.comArcus Biosciences (NYSE:RCUS) Shares Down 4.6% - Here's What HappenedJuly 15, 2025 | marketbeat.comArcus Biosciences' Quemliclustat Gets Orphan Drug Status For ... - NasdaqJuly 12, 2025 | nasdaq.comArcus Biosciences’ cancer drug gets orphan drug statusJuly 11, 2025 | msn.comArcus Biosciences' Pancreatic Cancer Treatment Gets Orphan Drug StatusJuly 11, 2025 | marketwatch.comArcus Biosciences’ Quemliclustat Receives Orphan Drug Designation for Pancreatic CancerJuly 11, 2025 | finance.yahoo.comArcus Biosciences (NYSE:RCUS) Shares Gap Up - Here's WhyJuly 10, 2025 | marketbeat.comArcus Biosciences' Quemliclustat Receives Orphan Drug Designation for Pancreatic CancerJuly 10, 2025 | gurufocus.comArcus Biosciences (NYSE:RCUS) Stock Price Up 8.1% - Should You Buy?July 9, 2025 | marketbeat.comArcus Biosciences Announces New Employment Inducement GrantsJuly 9, 2025 | businesswire.comArcus Biosciences (NYSE:RCUS) Trading Down 2.9% - Here's What HappenedJuly 3, 2025 | marketbeat.comArcus Biosciences Presents First Postive Data for Oral Metastatic Kidney Cancer TreatmentJuly 1, 2025 | msn.comArcus Biosciences (NYSE:RCUS) Trading Down 6.3% - Here's What HappenedJune 27, 2025 | marketbeat.comArcus Biosciences Announces New Employment Inducement Grants - Business WireJune 26, 2025 | businesswire.comPrecision Bio's DMD Therapy Gets Rare Pediatric Status, But Stock Slides; Retail Crowd Sees ‘Good Risk-Reward’June 26, 2025 | msn.comPrecision BioSciences Shares Surge Following FDA Rare Pediatric Disease DesignationJune 25, 2025 | msn.comPrecision BioSciences gets FDA rare disease status for DMD treatment, stock jumps 10%June 25, 2025 | msn.comArcus Biosciences, Inc. (RCUS) Cash Flow - Yahoo FinanceJune 24, 2025 | finance.yahoo.comRCUS Arcus Biosciences, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comArcus Biosciences Announces New Employment Inducement GrantsJune 24, 2025 | businesswire.comArcus Biosciences (NYSE:RCUS) Shares Down 3.8% - What's Next?June 11, 2025 | marketbeat.comStock Traders Purchase Large Volume of Call Options on Arcus Biosciences (NYSE:RCUS)June 11, 2025 | marketbeat.comArcus Biosciences Announces New Employment Inducement GrantsJune 10, 2025 | businesswire.com Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Email Address RCUS Media Mentions By Week RCUS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCUS News Sentiment▼1.280.71▲Average Medical News Sentiment RCUS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCUS Articles This Week▼46▲RCUS Articles Average Week Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Krystal Biotech News Today ACADIA Pharmaceuticals News Today Vaxcyte News Today Ascentage Pharma Group International News Today Arcellx News Today ADMA Biologics News Today Zai Lab News Today Akero Therapeutics News Today Telix Pharmaceuticals News Today PTC Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RCUS) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcus Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access